Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
Haleon PLC ( (GB:HLN) ) has shared an announcement.
Haleon PLC has disclosed transactions by Persons Discharging Managerial Responsibilities (PDMRs) in line with UK Market Abuse Regulations. The announcement detailed the acquisition of shares by Adrian Morris, General Counsel, and Tamara Rogers, Chief Marketing Officer, under the company’s Share Reward Plan, indicating a strategic move to align managerial interests with company performance.
More about Haleon PLC
Haleon PLC is a global leader in the consumer health industry, focusing on delivering better everyday health with a human touch. It offers a diverse product portfolio across five major categories: Oral Health, Pain Relief, Respiratory Health, Digestive Health, and Vitamins, Minerals and Supplements (VMS). The company is known for its long-standing, trusted brands such as Advil, Sensodyne, Panadol, and Centrum, which are grounded in scientific innovation and a deep understanding of consumer needs.
YTD Price Performance: -1.51%
Average Trading Volume: 18,827,511
Technical Sentiment Consensus Rating: Sell
Current Market Cap: £33.65B
For detailed information about HLN stock, go to TipRanks’ Stock Analysis page.
